{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:59:59Z","timestamp":1792699199099,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.forsciint.2023.111891","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T22:46:34Z","timestamp":1701125194000},"page":"111891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales"],"prefix":"10.1016","volume":"354","author":[{"given":"L.J.","family":"Hikin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rice-Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Couchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PR","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SR","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2023.111891_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/164_2018_154","article-title":"Designer benzodiazepines: another class of new psychoactive substances","volume":"252","author":"Moosmann","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.forsciint.2023.111891_bib2","unstructured":"UNODC. Global SMART Update Volume 18. \u3008https:\/\/www.unodc.org\u3009 [Last accessed 07\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib3","unstructured":"UNODC. Current NPS Threats Volume II. Vol. UNODC, Vienna. Current NPS Threats (unodc.org) [Last accessed 07\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib4","unstructured":"Critical Review Report: Bromazolam. Expert Committee on Drug Dependency 45th Meeting. \u3008https:\/\/www.who.int\/groups\/who-expert-committee-on-drug-dependence\/45th-ecdd-documents\u3009 [Last accessed 28\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib5","unstructured":"Psychoactive substances act 2016 (NPS) \u3008https:\/\/www.legislation.gov.uk\/ukpga\/2016\/2\/contents\/enacted\u3009 [Last accessed 28\/05\/23]."},{"issue":"6","key":"10.1016\/j.forsciint.2023.111891_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ph14060560","article-title":"Designer benzodiazepines: a review of toxicology and public health risks","volume":"14","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.forsciint.2023.111891_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1570159X18666200110121333","article-title":"New\/designer benzodiazepines': an analysis of the literature and psychonauts' trip reports","volume":"18","author":"Orsolini","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.forsciint.2023.111891_bib8","unstructured":"Novel benzodiazepines (benzos) produce some similar effects to prescription benzos but are often more potent and unpredictable. Melbourne: Victoria Department of Health; 2022 (https:\/\/www.health.vic.gov.au\/drug-alerts\/high-potency-benzodiazepine-tablets) [Last accessed 28\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/164_2018_110","article-title":"Fatal poisonings associated with new psychoactive substances","volume":"252","author":"Kronstrand","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2023.111891_bib10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jat\/bkaa098","article-title":"Quantification of Flualprazolam in Blood by LC-MS-MS: a case series of nine deaths","volume":"45","author":"Rice","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111891_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.forsciint.2023.111891_bib12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/dar.12959","article-title":"Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids","volume":"38","author":"Liang","year":"2019","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.forsciint.2023.111891_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0025802420973814","article-title":"Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases","volume":"61","author":"Hikin","year":"2021","journal-title":"Med. Sci. Law"},{"issue":"7","key":"10.1016\/j.forsciint.2023.111891_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jat\/bkab106","article-title":"Etizolam blood concentrations in 191 forensic cases in Ontario, Canada (2019-2020)","volume":"46","author":"Watts","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111891_bib15","unstructured":"\u3008https:\/\/www.caymanchem.com\/product\/22665\/bromazolam\u3009 [Last accessed 28\/05\/23]."},{"issue":"3","key":"10.1016\/j.forsciint.2023.111891_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.scijus.2017.12.004","article-title":"The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines (PDF)","volume":"58","author":"Waters","year":"2018","journal-title":"Sci. Justice"},{"key":"10.1016\/j.forsciint.2023.111891_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances-designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.forsciint.2023.111891_bib18","article-title":"A review of the updated pharmacophore for the alpha 5 GABA(A) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.forsciint.2023.111891_bib19","unstructured":"Europol 2016 Annual Report on the implementation of Council Decision 2005\/387\/JHA. EMCDDA\" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Union Agency for Law Enforcement Cooperation (Europol). 2017."},{"key":"10.1016\/j.forsciint.2023.111891_bib20","unstructured":"Bromazolam. Willow Grove (PA): Center for Forensic Science Research & Education; 2022 (\u3008https:\/\/www.npsdiscovery.org\/wp-content\/uploads\/2020\/05\/Bromazolam_050120_NMSLabs_Report.pdf\u3009 (accessed 21\/11\/2022)."},{"issue":"Issue 4","key":"10.1016\/j.forsciint.2023.111891_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in postmortem cases\u2014A British Columbia Perspective","volume":"Volume 47","author":"M\u00e9rette","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111891_bib22","unstructured":"Bromazolam assessment form. Helsinki: Finnish Medicines Agency; 2021 (\u3008https:\/\/ec.europa.eu\/growth\/toolsdatabases\/tris\/index.cfm\/fr\/search\/?trisaction=search.detail&year=2021&num=726&iLang=EN\u3009 (accessed 21\/11\/2022)."},{"key":"10.1016\/j.forsciint.2023.111891_bib23","unstructured":"First time bromazolam. Bluelight; 2022 (\u3008https:\/\/bluelight.org\/xf\/threads\/first-time-bromazolam.922459\/\u3009 (accessed 21\/11\/2022)."},{"key":"10.1016\/j.forsciint.2023.111891_bib24","unstructured":"\u3008https:\/\/publichealthscotland.scot\/publications\/rapid-action-drug-alerts-and-response-radar-quarterly-report\/rapid-action-drug-alerts-and-response-radar-quarterly-report-january-2023\/trends\/\u3009 [Last accessed 29\/05\/23]."},{"issue":"8","key":"10.1016\/j.forsciint.2023.111891_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases","volume":"44","author":"Heide","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111891_bib26","unstructured":"Drug misuse in England and Wales: year ending June 2022. \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/crimeandjustice\/articles\/drugmisuseinenglandandwales\/yearendingjune2022\u3009 [Last accessed 11\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib27","unstructured":"\u3008https:\/\/www.unodc.org\/documents\/data-and-analysis\/cocaine\/Global_cocaine_report_2023.pdf\u3009 [Last accessed 29\/05\/23]."},{"key":"10.1016\/j.forsciint.2023.111891_bib28","unstructured":"Deaths related to drug poisoning in England and Wales: 2021 registrations 2021 UK census \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2021registrations\u3009 (accessed 11\/05\/23)."},{"key":"10.1016\/j.forsciint.2023.111891_bib29","unstructured":"\u3008https:\/\/www.emcdda.europa.eu\/news\/2021\/6\/report-highlights-public-health-risks-and-increasing-availability-designer-benzodiazepines-europe_en\u3009 [Last accessed 29\/05\/23]."},{"issue":"3","key":"10.1016\/j.forsciint.2023.111891_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/dta.3119","article-title":"What's in fake 'Xanax'?: a dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets","volume":"14","author":"Blakey","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2023.111891_bib31","unstructured":"\u3008https:\/\/www.justice.gov\/usao-edva\/pr\/florida-man-sentenced-selling-counterfeit-drugs-dark-net\u3009 (Last accessed 11\/05\/23)."},{"key":"10.1016\/j.forsciint.2023.111891_bib32","unstructured":"BC Coroners Service. (2021) Illicit Drug Toxicity Type of DrugData to December 31 \u3008https:\/\/www2.gov.bc.ca\/assets\/gov\/birthadoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug-type.pdf\u3009 [Last accessed 11\/5\/23]."},{"issue":"3","key":"10.1016\/j.forsciint.2023.111891_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0025802419845796","article-title":"The changing pattern of synthetic cannabinoid use within England, April 2014 to March 2018","volume":"59","author":"Sharp","year":"2019","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.forsciint.2023.111891_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.forsciint.2017.11.036","article-title":"Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: detection and quantitation a case series from early 2017","volume":"282","author":"Hikin","year":"2018","journal-title":"Forensic Sci. Int"},{"issue":"4","key":"10.1016\/j.forsciint.2023.111891_bib35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jat\/bkad004","article-title":"Designer benzodiazepines gidazepam and desalkygidazepam (Bromonordiazepam): what do we know?","volume":"47","author":"Maskell","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2023.111891_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106649","article-title":"Comparison of several immunoassays used in drugs of abuse screening: assessment against gold standard methods and calculation of measurement uncertainty","volume":"101","author":"Mina","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.forsciint.2023.111891_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson Bergstrand","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"82","key":"10.1016\/j.forsciint.2023.111891_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC-MS\/MS became routine in clinical diagnostics","author":"Seger","year":"2020","journal-title":"Clin. Biochem."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823003419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073823003419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:13:56Z","timestamp":1759947236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073823003419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"alternative-id":["S0379073823003419"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111891","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2023.111891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111891"}}